GENinCode (LON:GENI) Trading 24.3% Higher – What’s Next?

GENinCode Plc (LON:GENIGet Free Report)’s share price traded up 24.3% during mid-day trading on Tuesday . The company traded as high as GBX 4.98 ($0.06) and last traded at GBX 4.97 ($0.06). 420,112 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 1,017,303 shares. The stock had previously closed at GBX 4 ($0.05).

GENinCode Trading Up 2.6 %

The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The company has a market cap of £7.08 million, a price-to-earnings ratio of -80.00 and a beta of 0.66. The firm has a 50-day moving average price of GBX 3.84 and a 200 day moving average price of GBX 4.95.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.